Walt Disney Co vs Erasca Inc. Common Stock — how do they compare? Walt Disney Co trades at $106.96 (market cap $184.79B), while Erasca Inc. Common Stock trades at $15.35 (market cap $5.40B). The key difference: Walt Disney Co is far larger — about 34.2× Erasca Inc. Common Stock's market cap, and Walt Disney Co pays a 1.4% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Walt Disney Co for 199 Days and Erasca Inc. Common Stock for 0 Days on average.
| DIS | ERAS | |
|---|---|---|
Market Cap | $184.79B | $5.40B |
Volume | 13,033,550 | 9,533,185 |
Sector | Media | Health |
52-Week High | $116.65 | $22.47 |
52-Week Low | $92.40 | $2.20 |
Typical Hold Time | 199 Days | 0 Days |
Enterprise Value | $225.65B | $5.18B |
Dividend Yield | 1.4% | — |
Signals from Pluang's Aura AI — not financial advice
Disney (DIS) trades at $104.76, up 0.7% with a bullish technical signal supported by moving averages. The company shows strong fundamental momentum with three consecutive quarterly earnings beats and robust revenue growth reaching $94.43 billion in 2025. Disney's net income margin expanded significantly to 13.13% while maintaining a reasonable P/E ratio of 22.07. Recent news highlights the company's $60 billion parks investment and streaming margin improvements above 13%.
Disney presents a compelling investment case with analyst consensus pointing to 20% upside to the $125.67 price target. The company's diversified entertainment ecosystem and accelerating DTC profitability support growth, though risks include free cash flow pressure from elevated investments and competitive streaming landscape. Institutional sentiment remains positive with 62.5% buy ratings among 64 analysts covering the stock.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →